Revenue (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Patient services
Capitated revenue	$	18,056	$	16,355	$	51,410	$	44,815
FFS revenue	35,578		28,272		105,923		73,978
Subtotal	53,634		44,627		157,333		118,793
Dispensary revenue	26,792		18,839		76,228		57,736
Clinical research trials and other revenue	1,609		1,511		4,890		4,530
Total	$	82,035	$	64,977	$	238,451	$	181,059